Loading...
Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options
An excess amount of glucocorticoids represents the primary and most frequent etiological factor influencing secondary osteoporosis. Patients receiving glucocorticoids, but also those with the endogenous form of hypercorticism, are at high risk for the loss of bone density, with the subsequent occurr...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3108700/ https://ncbi.nlm.nih.gov/pubmed/21701617 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|